Park Jong-gab holds 22.74% of Cellemics as co-representative director

insider · spotted Sep 2, 2026, 11:06 AM KST

• Park Jong-gab (박종갑) reports ownership of 2,259,634 shares, representing 22.74% of outstanding shares
• Park holds the position of co-representative director (공동대표이사) and is classified as a major shareholder (10%이상주주)
• Filing submitted 18 March 2026 under insider disclosure regime for officers and major shareholders (임원ㆍ주요주주특정증권등소유상황보고서)

As a co-representative director holding over 22% of shares, Park Jong-gab's stake represents both significant voting control and potential conflict-of-interest risk in corporate governance decisions.

AI-generated summaries of public DART filings. May contain errors — always verify against the original (linked). Not investment advice.